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Comparison of the Effects of High versus Low-Polyphenol Dark Chocolate 
on Body Weight and Biochemical Markers: A Randomized Trial
Abstract
Background: Dark chocolate (DC) has amongst the highest content of polyphenols in foods, but the chocolate processing meth-
ods may greatly reduce this amount. Few studies addressed the possible detrimental effects of low polyphenol DC on body weight, 
glucose metabolism and lipid levels, and the potential role of cocoa flavanols in body weight control. Therefore, this study aimed to 
determine the effect of DC rich and DC low in polyphenols on BMI, fasting blood glucose, high sensitivity C-reactive protein (hs-CRP) and lipid levels in adults.
Methods: Sixty-one participants took part in a randomized parallel trial. Volunteers randomly received 20g daily of either PRDC 
(polyphenol-rich DC) or of low polyphenol DC (LPDC) for four weeks. Anthropometric measures and blood samples were collected at baseline and after 4 weeks. 
Results: A significant net increase in BMI (0.17 ± 0.32 kg/m2, p = 0.007), fasting blood glucose (0.44 ± 1.08 mmol/l, p = 0.041) and 
triglycerides levels (0.13 ± 0.23 mmol/l, p = 0.008) was observed in the low polyphenol DC group following the 4 weeks intervention, 
while the levels of these parameters did not significantly change in the polyphenol-rich DC group. There was no significant change in 
hs-CRP levels in both groups. 
Conclusions: Results show that the intake of PRDC seems to be more metabolically healthy than LPDC intake, and this highlights the 
potential role of polyphenols in counteracting the negative effects of fat and energy intake in chocolate. The outcomes raise concerns about the polyphenol content and quality of DC products in the market. Further studies are needed to fully investigate the health 
benefits of dark chocolate intake, compare the effects of different types of chocolate and establish the necessary guidelines of the type 
and content of polyphenols in the chocolate preparations to ensure their favourable effect on health.
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This trial was registered at clinicaltrials.gov as NCT01749020
Polyphenols constitute a class of phytochemicals widely available in plants and are largely abundant in the human diet [1]. Polyphe-
nols have been previously implicated in many health benefits including prevention and management of diabetes, cardiovascular diseases 
(CVD), cancer and neurodegenerative diseases. These effects may be explained by the antioxidant capacity of polyphenols [2,3]. Recently, 
polyphenols have been involved in the modification of physiological and molecular mechanisms related to adiposity and energy metabo-
lism [4] suggesting a role for these components in obesity and body weight control. As obesity (particularly visceral obesity) may lead 
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Dark chocolate consists of cocoa liquor and cocoa butter (contains 33% of stearic acid, 33% of oleic acid and 25% of palmitic acid) 
[6], and is one of the major contributors to polyphenol intake in the western diet [7]. Cocoa polyphenols mainly consist of flavanols 
(including epicatechin, catechin and procyanidins) and quercetin-type flavanols [8]. Flavanols, along with theobromine and caffeine, are 
responsible for the astringent taste of chocolate [9,10]. Nonetheless, the amount of polyphenols in DC mainly depends on the method 
of processing. Examples of such methods are fermentation and dutching, which result in improved flavour and taste but might cause a 
significant loss or damage of polyphenols [10]. Hence, the amount of flavanols in two different commercial types of chocolate with equal 
cocoa concentrations can markedly differ from one chocolate to another, depending on the level of processing [10,11]. In the last decade, 
many studies highlighted the effects of cocoa/chocolate on health due to its high polyphenol/flavanols content [12]. However, few other 
studies discussed the potential detrimental effects of a low polyphenol chocolate on biochemical and anthropometric markers [13-15], 
and the possible role of polyphenols in countering the negative effects of fat (from cocoa butter) in chocolate [13,16]. Indeed, DC can 
be a significant source of fat and sugar [10]. Animal studies have been promising in demonstrating that polyphenols (and specifically 
flavanols) in cocoa decrease body weight gain in rats and mice [17-19]. In addition, a human observational study including 1018 indi-
viduals showed an inverse correlation between high chocolate consumption and BMI [20]. Overall, with DC products being increasingly 
marketed for their health benefits, and knowing that processing methods may cause a substantial decrease in the DC polyphenol content, 
it is important to explore whether benefits DC consumption apply to all types of dark chocolate in the market; or alternatively, that some 
DC products deficient in polyphenols might not produce such favourable effects, and thus be detrimental to health. Therefore, this study 
aimed to elucidate the beneficial effects of PRDC on biochemical (including glucose and serum lipid levels) and anthropometric (BMI, 
waist circumference) measurements, and to identify any potential adverse effects resulting from LPDC consumption.
The ethical approval for the study was granted by the division of Health Sciences Ethics Committee at Queen Margaret University 
(QMU). The studies were performed according to the declaration of Helsinki [21]. Participants were provided a written information sheet, and were asked to sign a consent form before taking part. 
The study was a randomized single-blinded controlled parallel study where participants received either 20g of LPDC or PRDC daily 
for a period of 4 weeks. A summary of the nutritional and chemical composition of the LPDC and the PRDC is presented in Table 1. The 
two types of chocolate looked identical, and contained 63.5% of cocoa solids. In order to avoid confounding factors, the two dark choco-
late types were matched for macronutrient and micronutrient content, and contained similar amounts of caffeine and theobromine. 
They only differed in polyphenols content; with the PRDC providing 500 mg total polyphenols (400 mg flavanols) and the LPDC substan-
tially less (< 60 mg flavanols). The products were provided by Barry-Callebaut Company, Belgium. PRDC and LPDC were produced via a 
method called “Acticoa” - patented trademark of Barry-Callebaut, which aims to naturally preserve polyphenols throughout the different 
steps of the manufacturing chain [22].
Participants were asked to attend two appointments (at baseline and after 4 weeks) which took place at Queen Margaret University 
research lab. BMI and waist circumference (WC), fasting blood glucose, hs-CRP and lipid levels (secondary outcomes) were assessed at 
each appointment. Randomization was implemented using sealed envelopes based on the protocol described by Doig and Simpson [23]. 
Standard-sized sheets were marked by either L (LPDC) or R (PRDC). The sheets were inserted into unlabelled envelopes and sealed. 
Then, the researcher or a member of the research team chose an envelope for each participant during the first appointment. 
Prior to the appointment, volunteers were asked to be in a fasting state, to avoid drinking alcohol for the past 24 hours, and to con-sume the last dose of DC at least 12 hours before the second appointment. In addition, they were requested to refrain from doing a high 
Subjects and Methods
Study Design
to low-grade inflammatory state that causes insulin resistance and endothelial dysfunction [5], lowering inflammation might improve glucose metabolism by increasing insulin sensitivity.
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Study population
Blood sampling and anthropometric measures
Volunteers were recruited via University email, flyers and posters in community and sports centres, hospitals, colleges and universi-
ties in Edinburgh, as well as via word-of-mouth. Participants were studied with no restriction to race or socioeconomic status according 
to the following criteria 1) Adults with no history of hypertension, type 2 diabetes or CVD; 2) Participants with BMI between “18.5-24.9 
kg/m2” and BMI between “25-34.9 kg/m2”; 3) Males and Females and 4) Age: 18-65 years. Exclusion criteria included history of CVD, 
hypertension, diabetes, intake of medications that affect insulin, glucose, lipids, and/or hs-CRP levels, intake of dietary supplements containing high doses of antioxidants (only low amounts of multivitamins were considered acceptable doses), and current smoking and 
heavy alcohol drinking (defined as more than 15 drinks/week for men and more than 8 drinks for women [25]). In addition, postmeno-
pausal women receiving hormone replacement therapy, and participants with regular consumption of cocoa or DC (> 1 serving/week) 
[7] were not eligible for participation.
Blood samples and anthropometric measurements (weight, height, and waist circumference) were taken before the start and at the end of the intervention (after 4 weeks). Height was measured twice with person barefoot using a stadiometer to the nearest 0.5 cm. 
Weight was measured in the morning at fasting using an electronic scale (Tanita BF-559, Body Fat Monitor/Scale) to the nearest 0.1 
Kg. Waist circumference was measured via a metal measuring tape calibrated against a steel tape, and was placed around the waist at the middle point between the lowest rib and the top of the hip bone. The tape was snug (without compressing the skin) and parallel to 
the floor [26]. Samples of blood were collected from the antecubital vein with minimal stasis by a butterfly needle (Vacuette®, Greiner bio-one). The blood sample drawn at each time was around or less than 20 ml. The samples were then centrifuged for 10 min at 4°C and 
3000 rpm (revolutions per minute; Thermo Scientific Heraeus Primo R centrifuge). The supernatant plasma was then harvested, and 
stored frozen in polystyrene tubes at -80°C for subsequent analysis. Fasting serum lipids (Total cholesterol = TC, Triglyceride = TG, LDL 
level of physical activity at least 12 hours prior to the visit, and to avoid or reduce eating high quantities of foods rich in flavonoids (> 4 
mg/100g of selected foods [24]) one week before the start (run-in phase) and subsequently for the duration of the study. A list of foods 
rich in flavonoids (such as bananas, all berries, green tea and coffee) was provided to participants. Instructions were given before as-signing participants to a particular group.
Components (per 20g 
daily portion)
LPDC PRDC
Energy (kcal) 102 102Total fat (g) 7.34 7.34Carbohydrates (g) 7.44 7.44
Protein (g) 1.34 1.34
Total flavanols (mg) < 60 400Epicatechin (mg) 12 85Catechin (mg) 2 15
Caffeine (mg) 15 15Theobromine (mg) 150 150
Table 1: Nutritional and chemical composition of the experimental dark chocolate.
Data obtained from Barry-Callebaut company, Belgium. Total flavanols, epicatechin and catechin were analysed via LCMS method 
(Liquid chromatography–mass spectrometry). The amount of total polyphenols in the PRDC (500 mg) was assessed by Folin-Ciocal-
teu method, as provided by the company. The amount of 20g was the daily portion given to participants in the trial. The amounts of 
polyphenols, caffeine and theobromine provided by the company were validated by studies at the James Hutton Institute, Dundee, UK.
PRDC: Polyphenol-rich dark chocolate; LPDC: Low polyphenol dark chocolate
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Subjects were requested to complete a general questionnaire covering information on social characteristics, lifestyle habits and 
medical history. Participants were asked to maintain their life style throughout the intervention period, while avoiding flavanol-rich 
foods and substituting the experimental DC by another food. A diet adjustment was also considered so that DC possibly replaced an-other food of similar energy. The researcher helped in providing dietary advice for participants to help them achieve this goal. This hap-pened by asking participants about the types of snacks usually consumed. Energy composition of these snacks was assessed, and substi-tutions based on food energy content were suggested by the researcher. To monitor changes in dietary intake, participants were asked 
to fill a 3-day un-weighted diet diary twice: at the run-in phase and at week 3. Energy and macronutrient intakes were then analysed 
using NetWISP dietary software package (V 3.0). Changes in physical activity levels were assessed via a physical activity questionnaire 
at the run-in phase and during the second appointment (at week 4). Physical activity levels were then transformed into MET (Metabolic 
equivalent task)/hour. Furthermore, an acceptability questionnaire was designed to obtain data on whether it was palatable/accept-
able to consume the assigned portion of dark chocolate daily (either LPDC or PRDC). Compliance to the study protocol was assessed by: 
1) through the 3-day diet diary and physical activity questionnaire and 2) Directly asking participants whether they have consumed all 
the samples of chocolate daily as required. A high compliance was defined as the consumption of 85% or more (equivalent to missing no more than one sample a week) of the chocolate throughout the study. 
Continuous normally distributed data were expressed as mean ± SD. Data were analysed using SPSS for Windows version 19.0 
(SPSS, Chicago, IL). Heterogeneity was assessed using Levene’s test for equality of variances. Differences in baseline characteristics be-tween groups were examined using a two-tailed independent t-test. For within group comparisons, changes from baseline were analy-
sed using a two-tailed student’s paired t-test. For between-group differences, ANCOVA was carried out to adjust for potential baseline 
differences in the outcomes. Non parametric data were analysed using Mann Whitney tests. Significant changes were set at p ≤ 0.05.
The number of volunteers who completed the trial was 61 out of 64 subjects recruited. Two participants in the LPDC group (week 2 
and week 3) and one in the PRDC group (week 2) dropped out during the intervention. Reasons for dropouts were infection, travel com-
mitments, and one participant decided to drop out after starting a migraine medication. According to the BMI, 39 participants had a BMI 
< 25 Kg/m2, and 22 participants had a BMI > 25 Kg/m2. The baseline characteristics of the study population are presented in Table 2.
and HDL), glucose and hs-CRP levels were measured. The analysis of glucose and lipids profile in plasma samples was undertaken at the 
Queen’s Medical Research Institute, University of Edinburgh using an automated platform (COBAS, UK). The technician was blinded to 
randomisation assignment. Hs-CRP levels were analysed at QMU lab via high sensitivity enzyme immunoassay (ELISA method) (Gen-
way Biotech Inc, USA). Hs-CRP was considered as the test of choice when assessing inflammation in individuals with no history of CVD 
[27]. 
Questionnaires and diet diaries collection
Statistical analyses
Results
Study Population 
(n = 61)
LPDC (n = 30) PRDC (n = 31) Difference Between 
Groups PAge (years) 28.82 ± 8.89 28.13 ± 8.98 29.48 ± 8.89 0.48
Gender (M/F) 12/ 49 3/27 9/22 0.062
BMI (Kg/m2) 23.92 ± 4.17 24.08 ± 3.78 23.77 ± 4.57 0.4
WC (cm) 77.7 ± 10.52 76.83 ± 8.89 78.54 ± 11.98 0.14
Table 2: Baseline characteristics of study participants. There were no significant differences between the LPDC and the PRDC 
groups for age, gender, weight, BMI and WC when assessed via two-tailed independent t-test (p > 0.05). Mean ± SD for all such 
values. LPDC: Low polyphenol-dark chocolate; PRDC: Polyphenol-rich dark chocolate; WC: waist circumference.
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Figure 1:  Changes in glucose levels in the LPDC and PRDC after 4 weeks.
LPDC: Low polyphenol-dark chocolate, PRDC: Polyphenol-rich dark chocolate.
* Significant difference from pre intervention (baseline), p = 0.041).  Data were 
analysed using paired-t-test. Values expressed as means mean ± SEM. 
There was no significant difference in baseline glucose levels between the LPDC 
and PRDC groups (p = 0.27), when assessed via independent t-test.
Biochemical assessment
There was no significant change in blood glucose levels in the PRDC group after 4 weeks. However, glucose levels increased in the 
LPDC group (Figure 1). In addition, TC, HDL and LDL levels did not significantly change throughout the intervention in both groups (p > 
0.05), but TG levels increased significantly in the LPDC group but not significantly in the PRDC group (Table 3). No significant changes 
in the inflammatory marker hs-CRP in both PRDC group (from 1.35 ± 0.97 mg/L at baseline to 1.26  ±  0.88 mg/L after 4 weeks; ∆ = - 
0.09 ± 0.2 mg/l, p = 0.32), and LPDC group (from 1.5 ± 1.04 mg/L at baseline to 1.54 ± 1.12 after 4 weeks; ∆ = 0.04 ± 0.8 mg/L, p = 0.57) 
were noted.BMI status did not have a significant impact on the outcomes: there was no difference in the response to treatment when 
participants were stratified according to BMI (BMI < 25 Kg/m2 or BMI > 25 Kg/m2) in the LPDC (for TC, p = 0.35; LDL, p = 0.7; HDL, p = 0.25; TG, p = 0.59) and hs-CRP (p = 0.56), and the PRDC (for TC, p = 0.73; LDL, p = 0.44; HDL, p = 0.58; TG, p = 0.13) and hs-CRP (p = 
0.35) groups.
Lipid levels 
(mmol /L)
Pre-PRDC 
Mean ± SD
Post-PRDC 
Mean ± SD
∆ (Post-PRDC - 
Pre-PRDC)
p Pre- LPDC 
Mean ± SD
Post-LPDC 
Mean ± SD
∆ (Post-LPDC 
- Pre- LPDC)
p
TC 4.17 ± 1.07 4.23 ± 0.98 0.059 ± 0.76 0.68 4.26 ± 0.79 4.5 ± 1.15 0.24 ± 0.91 0.18LDL 2.23 ± 0.97 2.22 ± 1.06 -0.013 ± 0.66 0.92 2.23 ± 0.8 2.35 ± 1.08 0.12 ± 0.73 0.43HDL 1.56 ± 0.36 1.64 ± 0.34 0.08 ± 0.27 0.12 1.66 ± 0.35 1.73 ± 0.4 0.07 ± 0.24 0.12TG 0.83 ± .0.46 0.69 ± 0.23 -0.14 ± 0.43 0.07 0.83 ± 0.32 0.96 ± 0.37 0.13 ± 0.23* 0.008
Table 3: Changes in serum lipid levels from baseline following the intervention.
*Significant difference from pre intervention, p < 0.05. Data analysed using paired-test. Mean ± SD for all values
 TG: Triglycerides; WC: waist circumference; LPDC: Low polyphenol-dark chocolate; PRDC: Polyphenol-rich dark chocolate. 
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Analysis of differences from baseline showed that weight, BMI and WC did not significantly change in the PRDC group, whereas 
four weeks of daily DC low in polyphenols consumption increased weight in the LPDC group (Table 4). Subgroup analysis based on BMI 
(BMI < 25 Kg/m2 or BMI > 25 Kg/m2) did not show a difference in gained weight between normal weight and overweight participants 
in the LPDC group, when assessed via Mann Whitney test (p = 0.36).In the LPDC group, the mean difference (post-pre) (IQR) was 0.12 
Kg/m2 (0.41) for the normal weight population and 0.24 Kg/m2 (0.48) for the overweight population.
Assessment of diet diaries and compliance
ANCOVA measures were performed for the above assessed parameters, in order to assess any impact of baseline imbalances on the 
results. Analysis showed significant differences between the LPDC and PRDC groups for TG (p < 0.001), BMI (p = 0.028) and weight (p 
= 0.031), but not for waist circumference (p = 0.76), glucose (p = 0.27), hs-CRP (p = 0.31), TC (p = 0.35), HDL (p = 0.82) and LDL (p = 
0.51). None of the above mentioned variables violated the assumption of homogeneity of variance (Levene’s test > 0.05). 
Compliance was estimated to be 87%. This was calculated by asking participants about the number of times they have missed the 
daily portion of chocolate over the study period (28 days). The percentage of compliance was calculated for each participant, and the average percentage was considered for the 61 participants. Reported physical activity levels converted into metabolic equivalent task 
(MET) per week did not significantly change throughout the intervention in the LPDC group (Pre: 14.35 ± 14.01 MET/week; post: 
13.32 ± 14.76 MET/week, p = 0.36) and the PRDC group (Pre: 21.08 ± 17.09 MET/week; post: 20.37 ± 16.78 MET/week, p = 0.54). 
All participants provided self-reported diet diaries. Paired-sample analysis on the NetWISP software (V3.0) showed no significant 
differences in energy and macronutrient intake following the intervention in both groups. Participants whether on either the LPDC or 
PRDC have maintained their usual calorie intake throughout the study (Table 5). 
Anthropometric measures
Pre-PRDC 
Mean ± SD
Post-PRDC 
Mean ± SD
∆ (Post-PRDC - 
Pre-PRDC)
P Pre-LPDC 
Mean ± SD
Post-LPDC 
Mean ± SD
∆ (Post-LPDC 
- Pre-LPDC)
P
BMI (Kg/m2) 23.77 ± 4.57 23.76 ± 4.65 -0.01 ± 0.3 0.82 24.08 ± 3.78 24.25 ± 3.87 0.17 ± 0.32 0.007*
WC (cm) 78.54 ± 11.98 78.75 ± 11.8 0.21 ± 1.7 0.5 76.83 ± 8.89 76.96 ± 8.98 0.13 ± 0.84 0.42
Table 4: Changes in anthropometric measurements in LPDC and PRDC groups following the intervention.
* Significant difference from pre intervention, p < 0.05. Data analysed using paired-test. Mean ± SD for all values. 
LPDC: Low polyphenol-dark chocolate; PRDC: Polyphenol-rich dark chocolate.
Run-in period Week 3 Significance (p=)Energy (Kcal) LPDC (N = 30) 1799 ± 522 1746 ± 416 0.54
PRDC (N = 31) 1868 ± 564 1998 ± 644 0.1Carbohydrate (g) LPDC (N = 30) 226.9 ± 64 208.3 ± 58 0.28
PRDC (N = 31) 233 ± 61 234 ± 62 0.93
Protein (g) LPDC (N = 30) 64 ± 22.2 63.2 ± 19.5 0.99
PRDC (N = 31) 73 ± 41.7 84 ± 49.5 0.07Fat (g) LPDC (N = 30) 73.2 ± 32 73.4 ± 25 0.96
PRDC (N = 31) 72.6 ± 29.3 82.7 ± 34.3 0.08
Table 5: Mean differences in energy and macronutrient intakes between the run-in period and week 3.
Differences between run-in period and week 3 were not significant for energy and macronutrient, p > 0.05.
Data expressed as mean ± SD. Results were analysed using paired tests on the NetWISP dietary software package (V3).
LPDC: Low polyphenol-dark chocolate; PRDC: Polyphenol-rich dark chocolate.
Comparison of the Effects of High versus Low-Polyphenol Dark Chocolate on Body Weight and Biochemical 
Markers: A Randomized Trial
360
Citation: Grace Farhat., et al. “Comparison of the Effects of High versus Low-Polyphenol Dark Chocolate on Body Weight and Bio-chemical Markers: A Randomized Trial”. EC Nutrition 2.3 (2015): 354-364.
Figure 2:  Acceptability of treatment based on the type of intervention.
LPDC: Low polyphenol dark chocolate, PRDC: Polyphenol-rich dark chocolate.
Acceptability of treatment
Discussion
With regard to acceptability, it was found that LPDC was more acceptable to consume than PRDC (Figure 2). The reasons given for 
unacceptability were mainly the bitterness and intense flavour, the texture, and few subjects reported some side effects: nausea, bloat-ing, winds, stomach pain, and to a less extent the dark colour of the chocolate which made it less appealing. These complaints, although noteworthy, did not result in any dropout. 
Findings of this study showed that DC low in polyphenols increased BMI, glucose and TG levels in the LPDC group, whereas none 
of these parameters significantly changed in the PRDC group. However, no blank group was carried out in this study (see limitations 
section). These parameters were recognized as being risk factors for chronic diseases [28]. The increase in weight (0.57 ± 1.08 kg, p = 
0.011) following 4 weeks of LPDC consumption was only reported by the study of Al-Moosawi., et al. [13] in which the LPDC composi-
tion was similar to this study. In relation to lipid profile, a detrimental effect of low-polyphenol chocolate was reported by the study 
of Wang-polagruto., et al. [15], which showed that consuming a low flavanol cocoa drink (43 mg of flavanols) resulted in a decrease in 
HDL by 9.6%, while an increase in HDL by 6.6 % was noted in the high flavanol cocoa drink (446 mg of flavanols). Also, Baba., et al. [29] 
reported a beneficial effect of cocoa polyphenols on LDL oxidation and evidenced by a 9.4% increase in lag time for LDL oxidation after 
12 weeks of flavanol-rich cocoa consumption (p < 0.001). However, a significant decrease (19.8%) in the lag time for LDL oxidation 
was noted in participants in the control group (consuming 12g of sugar) [29]. Regarding the inflammatory marker hs-CRP, our find-
ings match those obtained by most of the intervention studies on dark chocolate which showed no significant effects of LPDC or PRDC 
on hs-CRP levels [30-33]. Hence, despite the increase in weight, low-polyphenol chocolate did not result in a significant change in this 
inflammatory marker. This could be due to the short term intervention of this study.
The increase in BMI, glucose and TG levels only in the LPDC group but not in the PRDC group, might suggest a possible counteract-
ing effect of PRDC (500 mg of polyphenols) on the adverse effects of the fat content of chocolate. In line with this, it was proposed that 
cocoa polyphenols might counteract the pro-oxidant effects of cocoa butter, and thus could help against an increase in weight as well 
an increase in glucose levels [16]. The outcomes could possibly be in agreement with the findings of animal studies which showed that 
cocoa polyphenols reduced weight gain in animals when administered high fat diets [17,19,34]. Although the aim of our study was to 
include the LPDC and PRDC in the context of a normocaloric diet, the increase in BMI might suggest that this product was consumed 
in addition to the diet of participants. Nevertheless, the analysis of diet diaries did not show a significant increase in energy intake 
between baseline and week 3 in LPDC and the PRDC groups. This might be mostly caused by under-reporting, which is common in 
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The mechanism involved in the countering effect of PRDC on weight gain might be explained by the inhibitory effect of PRDC on 
fatty acid gene expression [17] or on digestive enzymes [37]. The implication of the latter mechanism might provide an explanation for 
the adverse effects (such as bloating) noted in some subjects of this study. In fact, this might be due to changes in bowel function caused by the fractions of fat and carbohydrate that were unabsorbed. As the possible mechanisms were mainly studied in animals and in vitro cell studies, human studies investigating the mode of action of polyphenols would then be required.Our results suggest that common chocolate products in the market (assumed to be of unknown or low in active polyphenols con-
tents) could cause unfavourable effects on health. In addition, the outcome on TG levels refutes the theory that chocolate consumption 
has presumably a neutral effect on lipid profile [12]. Our findings raise concerns over the different types of DC in the market, as certain 
current methods of processing might cause a considerable loss or damage of polyphenols [38]. In fact, chocolate companies may choose 
to increase product palatability by masking the astringent flavour of flavanols and thereby increasing consumer acceptability. This may 
involve the use of processing methods that might cause major polyphenol damage or losses. Indeed, qualitative data from our study re-inforces the idea that low polyphenol DC is more acceptable and preferable than high polyphenol DC due to its reduced bitterness taste. 
If evidence for the health benefits of DC continues to accrue, studies that confirm the content of polyphenols in DC in the market may become crucial, and indeed the need for legislation regarding the labelling of polyphenol content of chocolate could be considered.
It is important to mention that although changes in the LPDC group (increase in BMI and Triglycerides levels) were small and might not be considered clinically relevant, a longer term study might have led to larger and more relevant changes. Therefore, results 
obtained constitute an important basis for carrying out larger studies investigating the long term effects of PRDC and LPDC on anthro-pometric, biochemical and physiological markers. 
Some limitations are inherent to this study. The short study duration did not elucidate whether the effects noted are purely short 
term or might persist for a longer term. Women represented the largest proportion of both arms of the study, which may limit the generalization of the results. Furthermore, an inability to control the diet of participants resulted from the inclusion of free-living in-
dividuals who commonly exhibit a large variability in their dietary habits [39]. Therefore, we cannot exclude the possibility that they consumed other polyphenol-rich foods. Moreover, the compliance to intervention was not assessed by analysing total polyphenols in a 24-hour urine samples as a biochemical marker for compliance. Despite the limitations related to this test, it might have provided a 
better indication of adherence [40]. Also, body fat percentage was not assessed to indicate whether the increase in weight was caused 
by an increase in fat mass. In addition, differences in abiding to the dietary instructions provided by the researcher prior to the study can constitute an important limitation. The results of this study may not apply to regular DC consumers, who were among the exclu-
sion criteria; and due to the small changes observed, it cannot be ruled out that the inter individual differences in the bioavailability 
of polyphenols might have affected the results. Importantly, including a third arm in this study (blank control with no experimental 
chocolate) would have been helpful in providing a more valid explanation for the results obtained. Lastly, the effects obtained in the 
LPDC group might be attributed to the restriction of polyphenols intake in the LPDC group (as instructed) that might caused a change in 
their usual diet. Therefore, these results constitute a preliminary finding and justify carrying out further studies to elucidate the effect of low polyphenol DC and other chocolate products on anthropometric and biochemical markers.
research studies [34]. Indeed, under-reporting, along with overestimating physical activity, was previously documented in a cocoa 
study [35]. Therefore, we could suggest that participants of this study did not adhere to the dietary recommendations provided, and consumed the chocolate portion in addition to their diet, instead of substituting it for another food. Yet, the polyphenol content in the 
PRDC might have counteracted the harmful effects of increased energy and fat in DC, and prevented an increase in weight in the PRDC group.
Limitations
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Conclusion and Directions for Future Research
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polyphenols, increasing the tolerability of PRDC should probably be considered, and further research investigating ways of improving 
the taste of chocolate rich in polyphenol is justified.
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